Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves
Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves
Not authorised
- Lincomycin hydrochloride
- Spectinomycin sulfate tetrahydrate
Product identification
Medicine name:
Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves
Linspec 50/100 mg/ml Solução injetável para suínos, vitelos pré-ruminantes, cães e gatos
Active substance:
- Lincomycin hydrochloride
- Spectinomycin sulfate tetrahydrate
Target species:
-
Cattle
-
Dog
-
Cat
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Lincomycin hydrochloride54.49/milligram(s)1.00millilitre(s)
-
Spectinomycin sulfate tetrahydrate151.20/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal21day
-
-
Pig
-
Meat and offal14day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Revoked
Authorised in:
-
Portugal
Package description:
- 250 ml multi-dose translucent polypropylene vial with bromobutyl stopper and aluminium cap with a flip off seal. Vials is placed in an outer container (paper box).
- 100 ml multi-dose translucent polypropylene vial with bromobutyl stopper and aluminium cap with a flip off seal. Vial is placed in an outer container (paper box).
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Cenavisa S.L.
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 732/01/13DFVPT
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0238/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Portuguese (PDF)
Published on: 17/10/2024